A Multiple Dose Safety Study of PEG-IFN in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions

Healthy

Interventions

DRUG

BIIB017 (PEGylated Interferon Beta-1a)

Each participant will receive BIIB017 every other week or every 4 weeks.

DRUG

Placebo

Each participant will receive placebo every other week or every 4 weeks.

Trial Locations (1)

Research Site, Phoenix